Orforglipron was linked to consistent weight loss in addition to reductions in waist circumference, systolic blood pressure, triglycerides, non-HDL cholesterol and high-sensitivity C-reactive protein. In terms of safety, it was found to be noninferior to insulin glargine.
Heart failure patients with a CardioMEMS implant can now monitor their own pulmonary artery pressure reading and receive clinician feedback through a smartphone app.
Some parents may be unsure about giving their children these medications. However, it can be worth it to avoid a lifetime of high blood pressure and other potentially harmful health conditions.
Research has shown that mistreatment at the hands of patients and other visitors is one of the leading drivers of burnout in the U.S. healthcare system. The new Cardio Safe initiative was built to combat that issue and protect the well-being of cardiologists and other cardiovascular health professionals.
Children with congenital heart disease outgrow their replacement valves, requiring repeat open-heart surgeries. The Autus can be expanded using a transcatheter procedure.
The establishment of dedicated CPT codes represents an important step in the broader reimbursement for renal denervation to treat uncontrolled hypertension.
Cardiologists have always wanted a better way to identify heart patients in need of care early in their course of disease. Artificial intelligence may be the tool physicians have been waiting for.
